🇺🇸 FDA
Patent

US 7608641

Creatine oral supplementation using creatine hydrochloride salt

granted A61KA61K31/198A61P

Quick answer

US patent 7608641 (Creatine oral supplementation using creatine hydrochloride salt) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/198, A61P, A61P21/06